RENNANO Trademark

Trademark Overview


On Wednesday, February 24, 2021, a trademark application was filed for RENNANO with the United States Patent and Trademark Office. The USPTO has given the RENNANO trademark a serial number of 79313763. The federal status of this trademark filing is REGISTERED as of Tuesday, May 3, 2022. This trademark is owned by Biocytogen Pharmaceuticals (Beijing) Co., Ltd.. The RENNANO trademark is filed in the Pharmaceutical Products, Natural Agricultural Products, and Computer & Software Services & Scientific Services categories with the following description:

Vaccines; pharmaceutical preparations for the treatment of immune system related diseases and disorders; medicines for the treatment of cancer; diagnostic preparations for medical purposes; biochemical medicines for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases; medicines for human purposes for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases; drugs for medical purposes for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases; biological preparations for medical purposes for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases; active pharmaceutical ingredients being chemical and biological preparations for pharmaceutical purposes, namely, antibodies for the treatment of human and animal diseases; diagnostic preparations for medical and veterinary purposes; dietetic preparations adapted for medical use; medicines for veterinary purposes for the treatment of...

Live trees; live plants; live animals; poultry, live; pigs, live; hamsters, live; live laboratory animals; plant seeds; fodder; litter for animals

Conducting early evaluation in the field of new pharmaceutical products; development of products for others; consulting services in the field of technology development in the fields of pharmaceutical research and development; research and development of new products; pharmaceutical research services; quality control inspection in the field of pharmaceutical research and development; biochemical research and analysis; research and development services in the field of antibodies; medical and scientific research, namely, conducting clinical trials for others; biological research; development of pharmaceutical preparations and medicines; product testing; pharmaceutical products development services; evaluation of pharmaceuticals; technological research, namely, pharmaceutical research
rennano

General Information


Serial Number79313763
Word MarkRENNANO
Filing DateWednesday, February 24, 2021
Status700 - REGISTERED
Status DateTuesday, May 3, 2022
Registration Number6714941
Registration DateTuesday, May 3, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 15, 2022

Trademark Statements


Goods and ServicesVaccines; pharmaceutical preparations for the treatment of immune system related diseases and disorders; medicines for the treatment of cancer; diagnostic preparations for medical purposes; biochemical medicines for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases; medicines for human purposes for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases; drugs for medical purposes for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases; biological preparations for medical purposes for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases; active pharmaceutical ingredients being chemical and biological preparations for pharmaceutical purposes, namely, antibodies for the treatment of human and animal diseases; diagnostic preparations for medical and veterinary purposes; dietetic preparations adapted for medical use; medicines for veterinary purposes for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases
Goods and ServicesLive trees; live plants; live animals; poultry, live; pigs, live; hamsters, live; live laboratory animals; plant seeds; fodder; litter for animals
Goods and ServicesConducting early evaluation in the field of new pharmaceutical products; development of products for others; consulting services in the field of technology development in the fields of pharmaceutical research and development; research and development of new products; pharmaceutical research services; quality control inspection in the field of pharmaceutical research and development; biochemical research and analysis; research and development services in the field of antibodies; medical and scientific research, namely, conducting clinical trials for others; biological research; development of pharmaceutical preparations and medicines; product testing; pharmaceutical products development services; evaluation of pharmaceuticals; technological research, namely, pharmaceutical research

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, June 27, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class031 - Agricultural, horticultural and forestry products and grains not included in other classes; live animals; fresh fruits and vegetables; seeds, natural plants and flowers; foodstuffs for animals; malt.
US Class Codes001, 046
Class Status Code6 - Active
Class Status DateSunday, June 27, 2021
Primary Code031
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, June 27, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBiocytogen Pharmaceuticals (Beijing) Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCN

Party NameBiocytogen Pharmaceuticals (Beijing) Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCN

Party NameBiocytogen Pharmaceuticals (Beijing) Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCN

Trademark Events


Event DateEvent Description
Saturday, March 25, 2023NEW REPRESENTATIVE AT IB RECEIVED
Monday, October 10, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Sunday, September 4, 2022GENERIC MADRID TRANSACTION SENT TO IB
Sunday, September 4, 2022GENERIC MADRID TRANSACTION CREATED
Wednesday, August 3, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 3, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, February 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 15, 2022PUBLISHED FOR OPPOSITION
Monday, February 14, 2022NOTIFICATION PROCESSED BY IB
Wednesday, January 26, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 26, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, January 8, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 7, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 7, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 7, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 5, 2021REFUSAL PROCESSED BY IB
Friday, October 8, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, October 8, 2021REFUSAL PROCESSED BY MPU
Friday, September 24, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, September 23, 2021NON-FINAL ACTION WRITTEN
Sunday, September 19, 2021ASSIGNED TO EXAMINER
Thursday, July 1, 2021APPLICATION FILING RECEIPT MAILED
Sunday, June 27, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 24, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB